These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 27890789

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
    Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S.
    J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes.
    König A, Döring B, Mohr C, Geipel A, Geyer J, Glebe D.
    J Hepatol; 2014 Oct; 61(4):867-75. PubMed ID: 24845614
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Fälth M, Stindt J, Königer C, Nassal M, Kubitz R, Sültmann H, Urban S.
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids.
    Kirstgen M, Lowjaga KAAT, Müller SF, Goldmann N, Lehmann F, Alakurtti S, Yli-Kauhaluoma J, Glebe D, Geyer J.
    Sci Rep; 2020 Dec 10; 10(1):21772. PubMed ID: 33303817
    [Abstract] [Full Text] [Related]

  • 10. Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors.
    Goh B, Choi J, Kang JA, Park SG, Seo J, Kim TY.
    J Pharm Biomed Anal; 2020 Jan 30; 178():112959. PubMed ID: 31722821
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NTCP Oligomerization Occurs Downstream of the NTCP-EGFR Interaction during Hepatitis B Virus Internalization.
    Fukano K, Oshima M, Tsukuda S, Aizaki H, Ohki M, Park SY, Wakita T, Wakae K, Watashi K, Muramatsu M.
    J Virol; 2021 Nov 23; 95(24):e0093821. PubMed ID: 34613794
    [Abstract] [Full Text] [Related]

  • 13. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M, Watashi K, Tsukuda S, Aly HH, Fukasawa M, Fujimoto A, Suzuki R, Aizaki H, Ito T, Koiwai O, Kusuhara H, Wakita T.
    Biochem Biophys Res Commun; 2014 Jan 17; 443(3):808-13. PubMed ID: 24342612
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes.
    Verrier ER, Colpitts CC, Bach C, Heydmann L, Zona L, Xiao F, Thumann C, Crouchet E, Gaudin R, Sureau C, Cosset FL, McKeating JA, Pessaux P, Hoshida Y, Schuster C, Zeisel MB, Baumert TF.
    Cell Rep; 2016 Oct 25; 17(5):1357-1368. PubMed ID: 27783949
    [Abstract] [Full Text] [Related]

  • 16. Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP.
    Appelman MD, Wettengel JM, Protzer U, Oude Elferink RPJ, van de Graaf SFJ.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug 25; 1866(8):158960. PubMed ID: 33932583
    [Abstract] [Full Text] [Related]

  • 17. Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.
    Tsukuda S, Watashi K, Iwamoto M, Suzuki R, Aizaki H, Okada M, Sugiyama M, Kojima S, Tanaka Y, Mizokami M, Li J, Tong S, Wakita T.
    J Biol Chem; 2015 Feb 27; 290(9):5673-84. PubMed ID: 25550158
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term trans-inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acid.
    Lowjaga KAAT, Kirstgen M, Müller SF, Goldmann N, Lehmann F, Glebe D, Geyer J.
    Am J Physiol Gastrointest Liver Physiol; 2021 Jan 01; 320(1):G66-G80. PubMed ID: 33174454
    [Abstract] [Full Text] [Related]

  • 20. NTCP opens the door for hepatitis B virus infection.
    Yan H, Liu Y, Sui J, Li W.
    Antiviral Res; 2015 Sep 01; 121():24-30. PubMed ID: 26071008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.